Study of Nebulisable Budesonide for Oral Inhalation of Paediatric ...

DG News

By Cathy Yarbrough san diego -- May 20, 2009 -- A phase 3 trial of a novel aqueous nebulised dispersion of budesonide for oral inhalation in the treatment of asthma in young children (CASTLE I), failed to meet its coprimary endpoints, ...

WhisperfromWallStreet.com - Nasdaq Morning gainers

TransWorldNews (press release), GA

Its proprietary product candidates in clinical development include Unit Dose Budesonide , a nebulized version of budesonide for the treatment of asthma in children; and MAP0004, an orally inhaled version of dihydroergotamine for the treatment of ...

MAP Drug Succeeds in Phase III

Morningstar.ca, Canada

This was a critical trial for the company after the failure of Unit Dose Budesonide , which did not demonstrate effectiveness in children with asthma. The company had a lucrative deal in place with AstraZeneca AZN that could have reached $860 million if ...

MAP Gets Boost on Positive Phase III Migraine Study BioWorld Online

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday ... Trading Markets (press release)

all 71 news articles

Novartis touts benefits of indacaterol over two COPD rivals

Pharma Times, UK

Also at the ATS meeting, data was presented which demonstrated that Spiriva added to AstraZeneca's Symbicort ( budesonide /formoterol) provided greater clinical improvements than tiotropium alone over a 12-week treatment period. ...

Minafin acquires API manufacturing plant of AstraZeneca

Trading Markets (press release), CA

... advanced cosmetology, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). Following the acquisition, MINAKEM and AstraZeneca have signed a supply agreement for pharmaceutical products Budesonide , Omeprazole, and Esomeprazole.

Guidance offered on diagnosing, treating eosinophilic esophagitis

AAP News (subscription)

In addition, budesonide liquid is mixed with a viscous solution and swallowed. Both treatments have resulted in resolution of symptoms and histopathologic findings. The dosing of "topical steroids" and the duration of treatment still is under ...

Feisty 7-year-old doesn't let allergies to almost all foods stop him

Press-Enterprise, CA

Although no FDA-approved drugs exist to treat EoE, Tanner swallows a sweet slurry containing a glucocorticoid steroid called Budesonide to coat his esophagus. Clinical trials to develop a drug are under way. The slurry and a regimen of other allergy ...

Afternoon Stocks In Play - presented by WhisperFromWallStreet.com ...

TransWorldNews (press release), GA

... treatment of dry eye; Budesonide , a Phase II clinical trial product, which targets inflammatory and allergic conditions of the eye; and Doxovir, a Phase II clinical trial product for the treatment of viral conjunctivitis and other viral infections. ...

Wall Street News Alert: Morning Watch: Trade Alert: MAPP, CERP

Trading Markets (press release), CA

Unit Dose Budesonide is being developed in collaboration with AstraZeneca for the potential treatment of asthma in children, and LEVADEX inhaled therapy is being developed for the potential treatment of migraine. In addition, MAP Pharmaceuticals ...

Alergologia - post py 2008

Medycyna Praktyczna, Poland

Lasserson TJ, Cates CJ, Ferrara G., Casali L.: Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst. Rev., 2008; 3: CD004106 26. ...

AstraZeneca : decision favorable d'une Cour contre Apotex.

Boursorama, France

(CercleFinance.com) - AstraZeneca a annonce qu'une Cour americaine a accede a sa requete pour empecher Apotex de lancer, aux Etats-Unis, une version generique du Pulmicort Respules ( budesonide inhalation suspension), l'anti-asthmatique phare du ...